Tegaserod Maleate Patent Expiration

Tegaserod Maleate is used for managing symptoms of irritable bowel syndrome. It was first introduced by Alfasigma Usa Inc in its drug Zelnorm on Jul 24, 2002.


Tegaserod Maleate Patents

Given below is the list of patents protecting Tegaserod Maleate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Zelnorm US5510353 Certain aminoguanidine compounds, pharmaceutical compositions containing them and their use in treating gastrointestinal motility disorders and disorders associated with cephalic pain Apr 26, 2013

(Expired)

Alfasigma



Tegaserod Maleate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List